SCHEMBL18705137

SCHEMBL18705137

CC(C)N1CC2(COCC2C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18705140 0.85 HRH3 (0.31) —
SCHEMBL19122487 0.83 — —
SCHEMBL18705139 0.81 — —
SCHEMBL20349574 0.78 — —
SCHEMBL16984140 0.73 SMN1; SMN2 (0.31) —
SCHEMBL19756431 0.73 SMN1; SMN2 (0.31) —
SCHEMBL22306023 0.73 — —
SCHEMBL18705136 0.68 HRH3 (0.36) —
SCHEMBL19121846 0.68 — —
SCHEMBL16659520 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10023570-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2018-07-17 — — US disclosed
US-20170096425-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA, INC. 2017-04-06 — — US disclosed
Send feedback